- Home
- Publications
- Publication Search
- Publication Details
Title
Integrin αvβ3 Signaling in Tumor-Induced Bone Disease
Authors
Keywords
-
Journal
Cancers
Volume 9, Issue 12, Pages 84
Publisher
MDPI AG
Online
2017-07-10
DOI
10.3390/cancers9070084
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A dose escalating phase I study of GLPG0187, a broad spectrum integrin receptor antagonist, in adult patients with progressive high-grade glioma and other advanced solid malignancies
- (2016) Geert A. Cirkel et al. INVESTIGATIONAL NEW DRUGS
- The Bone Microenvironment: a Fertile Soil for Tumor Growth
- (2016) Denise Buenrostro et al. Current Osteoporosis Reports
- Matrix rigidity regulates the transition of tumor cells to a bone-destructive phenotype through integrin β3 and TGF-β receptor type II
- (2015) Jonathan M. Page et al. BIOMATERIALS
- Avβ3 integrin: Pathogenetic role in osteotropic tumors
- (2015) Stefania Stucci et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- HIF targets in bone remodeling and metastatic disease
- (2015) Rachelle W. Johnson et al. PHARMACOLOGY & THERAPEUTICS
- Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial
- (2014) Roger Stupp et al. LANCET ONCOLOGY
- αv-Integrin isoform expression in primary human tumors and brain metastases
- (2013) Alexander Vogetseder et al. INTERNATIONAL JOURNAL OF CANCER
- v Integrins in Angiogenesis and Cancer
- (2013) S. M. Weis et al. Cold Spring Harbor Perspectives in Medicine
- Integrin αvβ3 and CD44 pathways in metastatic prostate cancer cells support osteoclastogenesis via a Runx2/Smad 5/receptor activator of NF-κB ligand signaling axis
- (2012) Aditi Gupta et al. Molecular Cancer
- Bisphosphonates in oncology
- (2011) Robert E. Coleman et al. BONE
- Bone Structural Components Regulating Sites of Tumor Metastasis
- (2011) Julie A. Sterling et al. Current Osteoporosis Reports
- The use of bisphosphonates in cancer treatment
- (2010) Robert Coleman Annals of the New York Academy of Sciences
- Integrins and bone metastasis: Integrating tumor cell and stromal cell interactions
- (2010) Jochen G. Schneider et al. BONE
- Advances in the biology of bone metastasis: How the skeleton affects tumor behavior
- (2010) Julie A. Sterling et al. BONE
- A randomized phase 2 study of etaracizumab, a monoclonal antibody against integrin αvβ3, ± dacarbazine in patients with stage IV metastatic melanoma
- (2010) Peter Hersey et al. CANCER
- TGF- Promotion of Gli2-Induced Expression of Parathyroid Hormone-Related Protein, an Important Osteolytic Factor in Bone Metastasis, Is Independent of Canonical Hedgehog Signaling
- (2010) R. W. Johnson et al. CANCER RESEARCH
- Matrix Rigidity Induces Osteolytic Gene Expression of Metastatic Breast Cancer Cells
- (2010) Nazanin S. Ruppender et al. PLoS One
- 3 Integrin Subunit Mediates the Bone-Resorbing Function Exerted by Cultured Myeloma Plasma Cells
- (2009) M. Tucci et al. CANCER RESEARCH
- Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling
- (2009) Kandice R. Levental et al. CELL
- Randomized Phase II Trial of Denosumab in Patients With Bone Metastases From Prostate Cancer, Breast Cancer, or Other Neoplasms After Intravenous Bisphosphonates
- (2009) Karim Fizazi et al. JOURNAL OF CLINICAL ONCOLOGY
- Runx2 association with progression of prostate cancer in patients: mechanisms mediating bone osteolysis and osteoblastic metastatic lesions
- (2009) J Akech et al. ONCOGENE
- Kindlin-2 (Mig-2): a co-activator of β3integrins
- (2008) Yan-Qing Ma et al. JOURNAL OF CELL BIOLOGY
- Stromal cell-derived factor-1 increase αvβ3 integrin expression and invasion in human chondrosarcoma cells
- (2008) Tzu-Hsiu Lai et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Randomized Phase II Study of Cilengitide, an Integrin-Targeting Arginine-Glycine-Aspartic Acid Peptide, in Recurrent Glioblastoma Multiforme
- (2008) David A. Reardon et al. JOURNAL OF CLINICAL ONCOLOGY
- TGF-β1 increases motility and αvβ3 integrin up-regulation via PI3K, Akt and NF-κB-dependent pathway in human chondrosarcoma cells
- (2007) Ying-Yi Yeh et al. BIOCHEMICAL PHARMACOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now